Clinical Trials
2 trialsNCT00089128 2018-07-12
Gemcitabine and Irinotecan in Treating Patients With Locally Advanced or Metastatic Bladder Cancer
Medical University of South Carolina
Phase 2 Terminated
NCT00066612 2012-11-02
S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy
SWOG Cancer Research Network
Phase 2 Completed